- Home
- GNW vs ZLAB Comparison
GNW vs ZLAB Comparison
Compare GNW & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNW
- ZLAB
- Stock Information
- Founded
- GNW 1871
- ZLAB 2013
- Country
- GNW United States
- ZLAB China
- Employees
- GNW N/A
- ZLAB N/A
- Industry
- GNW Life Insurance
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- GNW Finance
- ZLAB Health Care
- Exchange
- GNW Nasdaq
- ZLAB Nasdaq
- Market Cap
- GNW 3.5B
- ZLAB 3.4B
- IPO Year
- GNW 2004
- ZLAB 2017
- Fundamental
- Price
- GNW $8.69
- ZLAB $31.92
- Analyst Decision
- GNW Buy
- ZLAB Buy
- Analyst Count
- GNW 1
- ZLAB 6
- Target Price
- GNW $9.50
- ZLAB $57.22
- AVG Volume (30 Days)
- GNW 3.7M
- ZLAB 807.7K
- Earning Date
- GNW 11-05-2025
- ZLAB 11-11-2025
- Dividend Yield
- GNW N/A
- ZLAB N/A
- EPS Growth
- GNW 512.33
- ZLAB N/A
- EPS
- GNW 0.44
- ZLAB N/A
- Revenue
- GNW $7,261,000,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- GNW N/A
- ZLAB $42.62
- Revenue Next Year
- GNW N/A
- ZLAB $55.12
- P/E Ratio
- GNW $19.86
- ZLAB N/A
- Revenue Growth
- GNW N/A
- ZLAB 32.56
- 52 Week Low
- GNW $5.99
- ZLAB $20.17
- 52 Week High
- GNW $8.85
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- GNW 59.22
- ZLAB 46.25
- Support Level
- GNW $8.46
- ZLAB $26.67
- Resistance Level
- GNW $8.85
- ZLAB $33.06
- Average True Range (ATR)
- GNW 0.16
- ZLAB 1.37
- MACD
- GNW -0.01
- ZLAB 0.08
- Stochastic Oscillator
- GNW 64.13
- ZLAB 66.14
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.